Resmed (RMD) Share-based Compensation (2009 - 2026)

Resmed (RMD) has 18 years of Share-based Compensation data on file, last reported at $26.8 million in Q1 2026.

• For the quarter ending Q1 2026, Share-based Compensation rose 11.08% year-over-year to $26.8 million; the trailing twelve-month figure through Mar 2026 stood at $101.6 million (up 15.11% YoY), and the FY2025 full-year result was $91.7 million, up 14.31% from the prior year.
• Share-based Compensation for Q1 2026 stood at $26.8 million, down from $28.9 million in the prior quarter.
• Across five years, Share-based Compensation topped out at $28.9 million in Q4 2025 and bottomed at $15.9 million in Q1 2022.
• The 5-year median for Share-based Compensation is $20.2 million (2024), against an average of $20.7 million.
• The widest annual swing landed in 2022, when Share-based Compensation slipped 5.34%; it then gained 27.85% in 2025.
• A 5-year view of Share-based Compensation shows it stood at $16.5 million in 2022, then increased by 20.51% to $19.8 million in 2023, then advanced by 14.08% to $22.6 million in 2024, then gained by 27.85% to $28.9 million in 2025, then retreated by 7.42% to $26.8 million in 2026.
• The last three Share-based Compensation figures came in at $26.8 million (Q1 2026), $28.9 million (Q4 2025), and $21.2 million (Q3 2025), per Business Quant data.

Peer Comparison